Lipogems Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Lipogems General Information

Description

Developer of effective medical technologies designed to offer a compliant and reliable option for orthopedic issues. The company's system provides cushion and assistance for the healing process that contains a high concentration of reparative cells, does not decline with age and processing preserves the cell and tissue microarchitecture, enabling orthopedic physicians and scientists to reduce the risk of contamination through a simple and minimally invasive procedure.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Viale Bianca Maria 24
  • 20129 Milan(Lombardy)
  • Italy
+39 02
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Therapeutic Devices
Vertical(s)
Corporate Office
  • Viale Bianca Maria 24
  • 20129 Milan(Lombardy)
  • Italy
+39 02

Lipogems Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lipogems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 05-Mar-2025 Completed Generating Revenue
3. Later Stage VC 01-Nov-2024 Completed Generating Revenue
2. Later Stage VC 23-Dec-2022 $13.1M $18.3M Completed Generating Revenue
1. Later Stage VC (Series A) 27-Jun-2022 $5.19M $5.19M Completed Generating Revenue
To view Lipogems’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Lipogems Patents

Lipogems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4422594-A1 Microfragmented fat tissue as drug delivery system in liver cancer therapy Pending 26-Oct-2021
US-20240415972-A1 Microfragmented fat tissue as drug delivery system in liver cancer therapy Pending 26-Oct-2021
WO-2023072755-A1 Microfragmented fat tissue as drug delivery system in liver cancer therapy Inactive 26-Oct-2021
EP-3612231-A1 Drug delivery system Active 20-Apr-2017
EP-3612231-B1 Drug delivery system Active 20-Apr-2017 A61K9/148
To view Lipogems’s complete patent history, request access »

Lipogems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lipogems Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
ABC Company PE/Buyout Minority
LIFTT Venture Capital Minority
To view Lipogems’s complete investors history, request access »

Lipogems FAQs

  • When was Lipogems founded?

    Lipogems was founded in 2010.

  • Where is Lipogems headquartered?

    Lipogems is headquartered in Milan, Italy.

  • What is the size of Lipogems?

    Lipogems has 21 total employees.

  • What industry is Lipogems in?

    Lipogems’s primary industry is Biotechnology.

  • Is Lipogems a private or public company?

    Lipogems is a Private company.

  • What is Lipogems’s current revenue?

    The current revenue for Lipogems is .

  • How much funding has Lipogems raised over time?

    Lipogems has raised $26M.

  • Who are Lipogems’s investors?

    ABC Company and LIFTT have invested in Lipogems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process